Efficacy of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder previously treated with amphetamines: analyses from a randomized, double-blind, multicenter, placebo-controlled titration study-Reference-Cited by-同舟云学术

Efficacy of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder previously treated with amphetamines: analyses from a randomized, double-blind, multicenter, placebo-controlled titration study

Published:2012-12 Issue:1 Volume:13 Page:
ISSN:2050-6511
Container-title:BMC Pharmacology and Toxicology
language:en
Short-container-title:BMC Pharmacol Toxicol

Author:

Babcock Thomas,Dirks Bryan,Adeyi Ben,Scheckner Brian

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Link

http://link.springer.com/article/10.1186/2050-6511-13-18/fulltext.html

Reference35 articles.

1. Kessler RC, Adler L, Barkley R, Biederman J, Conners CK, Demler O, Faraone SV, Greenhill LL, Howes MJ, Secnik K: The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry. 2006, 163 (4): 716-10.1176/appi.ajp.163.4.716.

2. Pliszka SR, Crismon ML, Hughes CW, Conners CK, Emslie GJ, Jensen PS, McCracken JT, Swanson JM, Lopez M, The Texas Consensus Conference Panel on Pharmacotherapy of Childhood Attention-Deficit/Hyperactivity Disorder: The Texas Children's Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2006, 45 (6): 642-10.1097/01.chi.0000215326.51175.eb.

3. Canadian ADHD Resource Alliance: Canadian ADHD practice guidelines. CAP-guidelines 3rd edition. http://www.caddra.ca/cms4/pdfs/caddraGuidelines2011.pdf . Accessed September 13, 2012

4. Nutt DJ, Fone K, Asherson P, Bramble D, Hill P, Matthews K, Morris KA, Santosh P, Sonuga-Barke E, Taylor E: Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 2007, 21 (1): 10-

5. Arnold LE: Methylphenidate vs. amphetamine: comparative review. J Atten Disord. 2000, 3 (4): 200-10.1177/108705470000300403.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early life exposure to F-53B induces neurobehavioral changes in developing children and disturbs dopamine-dependent synaptic signaling in weaning mice;Environment International;2023-11

2. Epilepsy and Attention Deficit Hyperactivity Disorder: Connection, Chance, and Challenges;International Journal of Molecular Sciences;2023-03-09

3. New Drugs to Treat ADHD: Opportunities and Challenges in Research and Development;New Discoveries in the Behavioral Neuroscience of Attention-Deficit Hyperactivity Disorder;2022

4. A phase 1, randomized, double‐blind, placebo‐controlled study to evaluate the safety, tolerability, and pharmacokinetics of single and multiple doses of lisdexamfetamine dimesylate in Japanese and Caucasian healthy adult subjects;Neuropsychopharmacology Reports;2019-11-25

5. Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults;Cochrane Database of Systematic Reviews;2018-08-09